Company Filing History:
Years Active: 2004
Title: The Innovations of Marc Van De Craen
Introduction
Marc Van De Craen is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the study of caspases, which are crucial for the process of apoptosis. His work has implications for understanding various biological processes and diseases.
Latest Patents
Marc Van De Craen holds a patent for a novel caspase homologue. This invention pertains to the identification of a new murine caspase and its human counterpart. The newly discovered molecules are closely related to human/murine caspase-2 and human caspase-9. They possess all the essential amino acid residues involved in catalysis, including the QACRG box, and feature a minimal or absent prodomain. Notably, Northern blot analysis has shown that the mRNA expression of this new caspase is predominantly found in skin.
Career Highlights
Marc is affiliated with the Vlaams Interuniversitair Instituut Voor Biotechnologie, where he continues to advance research in biotechnology. His work has been instrumental in enhancing the understanding of caspases and their roles in cellular processes.
Collaborations
Marc has collaborated with esteemed colleagues such as Wim Declercq and Peter Vandenabeele, contributing to a rich environment of research and innovation.
Conclusion
Marc Van De Craen's contributions to the field of biotechnology, particularly through his patent on caspase homologues, highlight his role as an influential inventor. His work not only furthers scientific understanding but also opens avenues for future research and applications.